Status:
COMPLETED
The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma
Lead Sponsor:
Tongji Hospital
Conditions:
Gut Microbiota
Hepatocellular Carcinoma
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study was to explore the correlation between postoperative recovery of liver function and gut microbiota in patients with hepatocellular carcinoma (HCC). Liver resection patients w...
Detailed Description
Primary hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. At present, surgery is the first choice and the most effective way to treat it. Based on the case review...
Eligibility Criteria
Inclusion
- The patient is diagnosed with liver cancer by b-mode ultrasonography before the surgery.
- There is no antibiotic treatment, no severe diarrhea and regular diet within two weeks before the surgery.
- It perform laparoscopic or open hepatectomy.
- The postoperative pathological diagnosis is hepatocellular carcinoma.
Exclusion
- No hepatectomy is performed during the operation.
- The patient is't hepatocellular carcinoma due to the postoperative pathological diagnosis.
- No stool samples are collected during the perioperative period.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04303286
Start Date
October 1 2018
End Date
December 31 2020
Last Update
May 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The hepatic surgery of Tongji hospital
Wuhan, Hubei, China, 430030